Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Non-Current Deferred Tax Liability (2016 - 2025)

Standard Biotools (LAB) has disclosed Non-Current Deferred Tax Liability for 12 consecutive years, with $1.1 million as the latest value for Q3 2025.

  • On a quarterly basis, Non-Current Deferred Tax Liability rose 35.43% to $1.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.1 million, a 35.43% increase, with the full-year FY2024 number at $1.1 million, up 28.54% from a year prior.
  • Non-Current Deferred Tax Liability was $1.1 million for Q3 2025 at Standard Biotools, up from $1.1 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $7.2 million in Q3 2021 to a low of $620000.0 in Q3 2022.
  • A 5-year average of $2.2 million and a median of $1.1 million in 2022 define the central range for Non-Current Deferred Tax Liability.
  • Peak YoY movement for Non-Current Deferred Tax Liability: tumbled 91.42% in 2022, then surged 64.03% in 2023.
  • Standard Biotools' Non-Current Deferred Tax Liability stood at $4.3 million in 2021, then crashed by 75.63% to $1.1 million in 2022, then dropped by 20.28% to $841000.0 in 2023, then increased by 28.54% to $1.1 million in 2024, then increased by 5.37% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Non-Current Deferred Tax Liability are $1.1 million (Q3 2025), $1.1 million (Q2 2025), and $1.0 million (Q1 2025).